A big enhance of bile acid (BA) ranges has been acknowledged as a basic metabolic phenotype of numerous liver illnesses. Monitoring of BA profiles has been proposed for etiology differentiation on liver damage. Right here, we quantitatively profiled serum BAs of wholesome controls and 719 sufferers with persistent liver illness of 5 etiologies, hepatitis B virus (HBV), hepatitis C virus (HCV), nonalcoholic steatohepatitis (NASH), alcohol-induced liver illness (ALD), and first biliary cirrhosis (PBC), and investigated the generality and specificity of various etiologies. The uncooked knowledge have been deposited into MetaboLights (ID: MTBLS2459). We discovered that sufferers with HBV, HCV, and NASH seemed to be extra comparable, and ALD and PBC sufferers clustered collectively.
BA profiles, consisting of a complete focus of the 21 quantified BAs [total BAs (TBAs)], 21 BA proportions, and 24 BA related variables, have been extremely completely different among the many etiologies. Particularly, the full BAs was larger in ALD and PBC sufferers in contrast with the opposite three teams. The proportion of conjugated deoxycholates was the very best in HBV-infected sufferers. The ratio of 12α-hydroxylated (12α-OH) to non-12α-OH BAs was the very best in NASH sufferers. The proportion of taurine-conjugated BAs was the very best in ALD sufferers. For PBC sufferers, the proportion of ursodeoxycholate species was the very best, and the ratio of major to secondary BAs was the bottom.
Comparatively, the distinction of BA profiles amongst cirrhosis sufferers was constant however weaker than that of all sufferers. The correlations between BA profiles and scientific indices have been additionally fairly completely different in several pathological teams, each in all sufferers and in sufferers with cirrhosis. Total, our findings prompt that BA compositions are distinct amongst sufferers with completely different etiologies of persistent liver illness, and a few BA-relevant variables are of scientific potentials for liver damage kind differentiation, though additional validations on extra etiologies and populations are wanted.
Circulatory cadmium positively correlates with epithelial-mesenchymal transition in sufferers with persistent obstructive pulmonary illness
Environmental cadmium (Cd) publicity may cause a number of pulmonary illnesses. Epithelial-mesenchymal transition (EMT) concerned within the technique of persistent obstructive pulmonary illness (COPD). Nonetheless, the affiliation between environmental Cd publicity and EMT was unclear in COPD sufferers. This examine aimed to research the associations amongst circulatory Cd, EMT and COPD primarily based on case-control examine. 4 hundred COPD sufferers and 400 management topics have been recruited. Circulatory Cd was detected utilizing atomic adsorption spectrometer. MicroRNA-30 (miR-30) was measured by RT-PCR and the markers of pulmonary EMT have been evaluated by way of western blotting.
Circulatory Cd focus was elevated and serum miR-30 was decreased in COPD sufferers. Circulatory Cd was inversely related to pulmonary perform in COPD sufferers. Furthermore, serum miR-30 was regularly decreased in parallel with FEV1 in COPD sufferers. In the meantime, there was a unfavourable affiliation between serum miR-30 and circulatory Cd in COPD sufferers. Additional evaluation discovered that E-cadherin, certainly one of epithelial biomarkers, was diminished in lung tissues of COPD sufferers with larger circulatory Cd. Our outcomes present proof that miR-30 discount contributing to pulmonary EMT might contain within the technique of Cd-induced COPD.
Nationwide developments and outcomes of genetically inherited non-alcoholic persistent liver illness within the USA: estimates from the Nationwide Inpatient Pattern (NIS) database
Medical literature on the prevalence of genetic liver illness is missing. On this examine, we investigated the in-hospital healthcare and financial burden from genetic causes of non-alcoholic persistent liver illness (NACLD) and non-alcoholic liver cirrhosis (NALC) within the USA. Knowledge have been abstracted from the Nationwide Inpatient Pattern database between 2002 and 2014 utilizing ICD9 codes for sufferers discharged with NACLD and NALC secondary to genetic illnesses together with alpha-1 antitrypsin deficiency (A1ATd), cystic fibrosis (CF), Wilson illness (WD), hereditary hemochromatosis (HHC), glycogen storage illness, and issues of fragrant amino-acid metabolism (DAAAM).
All through the examine interval, there have been 19,332 discharges for NACLD related to the six genetic illnesses together with 14,368 for NALC. There have been $1.09 billion in hospital fees, 790 in-hospital deaths, and 955 liver transplants carried out. Total, A1ATd was related to 8,983 (62.52%) hospitalizations for NALC adopted by WD, CF, and HHC. The best in-hospital mortality was seen with HHC. The best frequency of liver transplants was seen with DAAAM. The variety of hospitalizations for genetic liver illnesses continues to extend. With elevated funding and directed analysis efforts, we are able to goal to enhance medical remedies and the standard of life for sufferers in danger for liver deterioration.
) Tissue, Section, Human Disease, Pulmonary Embolism, Lung (Frozen) |
|
MBS640865-5Slides |
MyBiosource |
5Slides |
EUR 755 |
Tissue, Section, Human Disease, Pulmonary Embolism, Lung (Frozen) |
|
MBS640865-5x5Slides |
MyBiosource |
5x5Slides |
EUR 3170 |
) Tissue, Section, Human Disease, Pulmonary Embolism, Lung (Paraffin) |
|
MBS640499-5Slides |
MyBiosource |
5Slides |
EUR 725 |
Tissue, Section, Human Disease, Pulmonary Embolism, Lung (Paraffin) |
|
MBS640499-5x5Slides |
MyBiosource |
5x5Slides |
EUR 3100 |
 tissue array) Lung disease spectrum (pulmonary cancer progression) tissue array |
|
LC2083 |
TissueArray |
each |
EUR 546 |
|
Description: Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases/208 cores |
Lung disease spectrum (pulmonary cancer progression) tissue array |
|
LC809 |
TissueArray |
each |
EUR 306 |
|
Description: Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases/80 cores |
, Pulmonary Embolism, Lung, BioGenomics) Tissue, Genomic DNA, Human Disease (Adult), Pulmonary Embolism, Lung, BioGenomics |
|
MBS654658-005mg |
MyBiosource |
0.05mg |
EUR 715 |
Tissue, Genomic DNA, Human Disease (Adult), Pulmonary Embolism, Lung, BioGenomics |
|
MBS654658-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3075 |
 Mini Samples ELISA Kit) Human Pulmonary Activation Regulated Chemokine (PARC) Mini Samples ELISA Kit |
|
MBS2087860-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5485 |
Human Pulmonary Activation Regulated Chemokine (PARC) Mini Samples ELISA Kit |
|
MBS2087860-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 370 |
Human Pulmonary Activation Regulated Chemokine (PARC) Mini Samples ELISA Kit |
|
MBS2087860-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 575 |
Human Pulmonary Activation Regulated Chemokine (PARC) Mini Samples ELISA Kit |
|
MBS2087860-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3030 |
Human Pulmonary Activation Regulated Chemokine (PARC) Mini Samples ELISA Kit |
|
MBS2087860-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
 ELISA Kit) Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) ELISA Kit |
|
MEB522Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 6628.14 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC). |
Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) ELISA Kit |
|
MEB522Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 651.02 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC). |
Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) ELISA Kit |
|
MEB522Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 878.6 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC). |
Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) ELISA Kit |
|
MEB522Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3593.72 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC). |
Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) ELISA Kit |
|
4-MEB522Mu |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 1 plate of 96 wells
- 5 plates of 96 wells
- 10 plates of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mini Samples Mouse Pulmonary Activation Regulated Chemokine (PARC) in samples from n/a with no significant corss-reactivity with analogues from other species. |
 Tissue cDNA, First Strand, Human Adult Disease, Lung, Pulmonary Embolism, BioGenomics |
|
MBS652409-40Tests |
MyBiosource |
40Tests |
EUR 1205 |
Tissue cDNA, First Strand, Human Adult Disease, Lung, Pulmonary Embolism, BioGenomics |
|
MBS652409-5x40Tests |
MyBiosource |
5x40Tests |
EUR 5200 |
 Single Donor Human Pulmonary Fibrosis Plasma |
|
IPLASPF |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human Pulmonary Fibrosis Plasma |
Single Donor Human Pulmonary Fibrosis Plasma |
|
MBS8421079-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Human Chronic Kidney Disease Peripheral Blood Mononuclear Cells |
|
ABC-TC4342 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Clinical data may include: Medication (current and historical), Disease Severity, Creatine Clearance Value, GFR, standard blood chemistry results, BNP. |
 Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis |
|
ABC-TC5520 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: IPF (Idiopathic Pulmonary Fibrosis) is a fatal disease that usually affects adults between the ages of 50-70. The disease is characterized by progressive decline in lung function resulting from scarring of lung tissue.IPF varies from person to person where in some, fibrosis happens quickly, while the process can be much slower in others. IPF has no cure yet and both geneticand environmental factors are attributed to the development of the disease. Genetics may play a role in causing IPF, and cigarette smoking is the most accepted risk factor in increasing the chances of developing IPF. Recent research has helped doctors understand the disease more closely so they can more quickly diagnose it than in the past. Efforts are still underway in the research community to understand the pathways of disease progression and subsequently develop cures for IPF. IPF was once thought to be a chronic inflammatory process but recent evidence suggests that the abnormal activation of alveolar epithelial cells (AECs) induce over-activation of fibrotic response. The fibroblast and myofibroblast foci secrete excessive amounts of collagens, leading to scarringand destruction of the lung architecture. The mechanisms that link IPF with ageing and aberrant epithelial activation are unknown. |
) Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase) |
|
ABC-TC3364 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-PB Plasma is obtained by centrifuging Chronic Myeloid Leukemia peripheral blood. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia plasma is available in the chronic phase and accelerated or blast crisis phase. |
) Human Chronic Myeloid Leukemia Bone Marrow Plasma (Chronic Phase) |
|
ABC-TC3361 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-Bone Marrow plasma is obtained by centrifugation of the Chronic Myeloid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia-Bone Marrow plasma is available in chronic phase and accelerated or blast crisis phase. |
 Plasma Membrane GFP Tagged Human Pulmonary Microvascular Endothelial Cells |
|
cAP-0032GFP-PM |
Angio Proteomie |
1Frozen Vial |
EUR 782.1 |
 Basic Plasma Cleaner, 115V |
|
PDC-32G* |
Harrick Plasma |
1 Unit |
Ask for price |
 Expanded Plasma Cleaner, 115V |
|
PDC-001* |
Harrick Plasma |
1 Unit |
Ask for price |
) p47 phox (NCF1, NOXO2, Neutrophil cytosolic factor 1, 47kD Chronic granulomatous disease, autosomal 1) |
|
MBS618074-01mg |
MyBiosource |
0.1mg |
EUR 975 |
p47 phox (NCF1, NOXO2, Neutrophil cytosolic factor 1, 47kD Chronic granulomatous disease, autosomal 1) |
|
MBS618074-5x01mg |
MyBiosource |
5x0.1mg |
EUR 4245 |
 High Power Expanded Plasma Cleaner, 115V |
|
PDC-001-HP* |
Harrick Plasma |
1 Unit |
Ask for price |
 Human Crohn's Disease PB Plasma |
|
ABC-TC3392 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Crohn's Disease peripheral blood plasma is obtained by centrifugation of the PB. This product has a diminished number of cells and platelets. Fresh Crohn's PB plasma is available upon request. |
 Heart Disease Plasma, Human Donor |
|
MBS170261-10Samples |
MyBiosource |
10Samples |
EUR 1895 |
Heart Disease Plasma, Human Donor |
|
MBS170261-1Sample |
MyBiosource |
1Sample |
EUR 310 |
Heart Disease Plasma, Human Donor |
|
MBS170261-5x10Samples |
MyBiosource |
5x10Samples |
EUR 8330 |
 Metanephrine ELISA kit Plasma samples |
|
BA-E-8100 |
ImmuSmol SAS |
1 kit |
EUR 462.24 |
|
Description: App. 1 year |
 ELISA Kit) Low Sample Volume Mouse Pulmonary Activation Regulated Chemokine / PARC (CCL18) ELISA Kit |
|
abx585726-100g |
Abbexa |
100 µg |
EUR 7087.5 |
Low Sample Volume Mouse Pulmonary Activation Regulated Chemokine / PARC (CCL18) ELISA Kit |
|
abx585726-10g |
Abbexa |
10 µg |
EUR 787.5 |
Low Sample Volume Mouse Pulmonary Activation Regulated Chemokine / PARC (CCL18) ELISA Kit |
|
abx585726-50g |
Abbexa |
50 µg |
EUR 3750 |
 Normetanephrine ELISA kit Plasma samples |
|
BA-E-8200 |
ImmuSmol SAS |
1 kit |
EUR 462.24 |
|
Description: App. 1 year |
) Human Chronic Lymphoid Leukemia PB Plasma(Relapsed/Refractory) |
|
ABC-TC3351 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Lymphoid Leukemia-PB Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia-PB-Mononuclear Cells. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
 Rheumatoid Factor Positive Plasma Samples |
|
MBS173639-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Single Donor Human Crohn's Disease Plasma |
|
IPLASCRHN |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human Crohn's Disease Plasma |
 Single Donor Human Heart Disease Plasma |
|
IPLASHDS1 |
Innovative research |
each |
EUR 247 |
|
|
|
Description: Single Donor Human Heart Disease Plasma |
Single Donor Human Heart Disease Plasma |
|
IPLASHDS10 |
Innovative research |
each |
EUR 2352 |
|
|
|
Description: Single Donor Human Heart Disease Plasma |
Single Donor Human Crohn's Disease Plasma |
|
MBS8421057-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Single Donor Human Graves Disease Plasma |
|
MBS8421062-10x01mL |
MyBiosource |
10x0.1mL |
EUR 355 |
 Plasma - Patient Samples - Troponin I |
|
MBS173717-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Plasma - Patient Samples - Troponin I |
|
MBS173718-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Dopamine ELISA kit Urine & Plasma samples |
|
BA-E-6300 |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
 Plasma - Patient Samples - Human Donors |
|
MBS170489-100Samples |
MyBiosource |
100Samples |
EUR 2360 |
Plasma - Patient Samples - Human Donors |
|
MBS170489-10Samples |
MyBiosource |
10Samples |
EUR 820 |
Plasma - Patient Samples - Human Donors |
|
MBS170489-1Sample |
MyBiosource |
1Sample |
EUR 220 |
Plasma - Patient Samples - Human Donors |
|
MBS170489-5x100Samples |
MyBiosource |
5x100Samples |
EUR 10405 |
 Histamine ELISA kit Urine & Plasma samples |
|
BA-E-1000 |
ImmuSmol SAS |
1 kit |
EUR 330.48 |
|
Description: App. 1 year |
 Epinephrine ELISA kit Urine & Plasma samples |
|
BA-E-6100 |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
) Human Chronic Myeloid Leukemia PB Plasma (Accelerated/Blast Crisis) |
|
ABC-TC3363 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-PB Plasma is obtained by centrifuging Chronic Myeloid Leukemia peripheral blood. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia plasma is available in the chronic phase and accelerated or blast crisis phase. |
) Human Chronic Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|
ABC-TC3350 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Lymphoid Leukemia-PB Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia-PB-Mononuclear Cells. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
 Norepinephrine ELISA kit Urine & Plasma samples |
|
BA-E-6200 |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
 Metanephrine ELISA kit Plasma samples - Research |
|
BA-E-8100R |
ImmuSmol SAS |
1 kit |
EUR 462.24 |
|
Description: App. 1 year |
 Single Donor Heart Disease Human Plasma |
|
MBS8421064-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Relapsed/Refractory) |
|
ABC-TC3345 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
 Normetanephrine ELISA kit Plasma samples - Research |
|
BA-E-8200R |
ImmuSmol SAS |
1 kit |
EUR 462.24 |
|
Description: App. 1 year |
 Dopamine ELISA kit Urine & Plasma samples - Research |
|
BA-E-6300R |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
 Histamine ELISA kit Urine & Plasma samples - Research |
|
BA-E-1000R |
ImmuSmol SAS |
1 kit |
EUR 330.48 |
|
Description: App. 1 year |
) Human Chronic Myeloid Leukemia Bone Marrow Plasma (Accelerated/Blast Crisis) |
|
ABC-TC3360 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-Bone Marrow plasma is obtained by centrifugation of the Chronic Myeloid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia-Bone Marrow plasma is available in chronic phase and accelerated or blast crisis phase. |
 Human Prorenin ELISA Kit for Non Plasma Samples |
|
MBS135506-1Kit |
MyBiosource |
1Kit |
EUR 595 |
Human Prorenin ELISA Kit for Non Plasma Samples |
|
MBS135506-5Kits |
MyBiosource |
5Kits |
EUR 2150 |
Human Prorenin ELISA Kit for Non Plasma Samples |
|
MBS135506-5x5Kits |
MyBiosource |
5x5Kits |
EUR 9935 |
Human Prorenin ELISA Kit for Non Plasma Samples |
|
MBS480474-1Kit |
MyBiosource |
1Kit |
EUR 800 |
Human Prorenin ELISA Kit for Non Plasma Samples |
|
MBS480474-5x1Kit |
MyBiosource |
5x1Kit |
EUR 3640 |
 Epinephrine ELISA kit Urine & Plasma samples - Research |
|
BA-E-6100R |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
) Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|
ABC-TC3344 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
 Norepinephrine ELISA kit Urine & Plasma samples - Research |
|
BA-E-6200R |
ImmuSmol SAS |
1 kit |
EUR 450.36 |
|
Description: App. 1 year |
 Free Metanephrine - Normetanephrine ELISA kit - Plasma samples |
|
BA-E-8300 |
ImmuSmol SAS |
1 kit |
EUR 951.48 |
|
Description: App. 1 year |
 3 Catecholamines ELISA kit Plasma & Urine samples |
|
BA-E-6600 |
ImmuSmol SAS |
1 kit |
EUR 1364.04 |
|
Description: App. 1 year |
 Plasma - Geriatric Samples - 3. Ages 85+ Years Old |
|
MBS170628-10Samples |
MyBiosource |
10Samples |
EUR 1450 |
Plasma - Geriatric Samples - 3. Ages 85+ Years Old |
|
MBS170628-1Sample |
MyBiosource |
1Sample |
EUR 280 |
Plasma - Geriatric Samples - 3. Ages 85+ Years Old |
|
MBS170628-5x10Samples |
MyBiosource |
5x10Samples |
EUR 6315 |
) p47 phox (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1 (47kD) |
|
MBS611915-01mg |
MyBiosource |
0.1mg |
EUR 655 |
p47 phox (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1 (47kD) |
|
MBS611915-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2800 |
p47 phox (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1 (47kD) |
|
MBS613114-02mL |
MyBiosource |
0.2mL |
EUR 830 |
p47 phox (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1 (47kD) |
|
MBS613114-5x02mL |
MyBiosource |
5x0.2mL |
EUR 3575 |
 Plasma - Geriatric Samples - 1. Ages 65-74 Years Old |
|
MBS170626-10Samples |
MyBiosource |
10Samples |
EUR 1450 |
Plasma - Geriatric Samples - 1. Ages 65-74 Years Old |
|
MBS170626-1Sample |
MyBiosource |
1Sample |
EUR 280 |
Plasma - Geriatric Samples - 1. Ages 65-74 Years Old |
|
MBS170626-5x10Samples |
MyBiosource |
5x10Samples |
EUR 6315 |
 Plasma - Geriatric Samples - 2. Ages 75-84 Years Old |
|
MBS170627-10Samples |
MyBiosource |
10Samples |
EUR 1450 |
Plasma - Geriatric Samples - 2. Ages 75-84 Years Old |
|
MBS170627-1Sample |
MyBiosource |
1Sample |
EUR 280 |
Plasma - Geriatric Samples - 2. Ages 75-84 Years Old |
|
MBS170627-5x10Samples |
MyBiosource |
5x10Samples |
EUR 6315 |
 Plasma - Pediatric Samples - 1. Ages 0-3 Years Old |
|
MBS170629-1Sample |
MyBiosource |
1Sample |
EUR 315 |
Plasma - Pediatric Samples - 1. Ages 0-3 Years Old |
|
MBS170629-5x1Sample |
MyBiosource |
5x1Sample |
EUR 4310 |
 Plasma - Pediatric Samples - 2. Ages 4-6 Years Old |
|
MBS170630-1Sample |
MyBiosource |
1Sample |
EUR 350 |
Plasma - Pediatric Samples - 2. Ages 4-6 Years Old |
|
MBS170630-5x1Sample |
MyBiosource |
5x1Sample |
EUR 4380 |
 Plasma - Pediatric Samples - 3. Ages 7-10 Years Old |
|
MBS170631-1Sample |
MyBiosource |
1Sample |
EUR 350 |
Plasma - Pediatric Samples - 3. Ages 7-10 Years Old |
|
MBS170631-5x1Sample |
MyBiosource |
5x1Sample |
EUR 4380 |
 Plasma - Pediatric Samples - 4. Ages 11-14 Years Old |
|
MBS170632-1Sample |
MyBiosource |
1Sample |
EUR 315 |
Plasma - Pediatric Samples - 4. Ages 11-14 Years Old |
|
MBS170632-5x1Sample |
MyBiosource |
5x1Sample |
EUR 4310 |
 Plasma - Pediatric Samples - 5. Ages 15-17 Years Old |
|
MBS170633-1Sample |
MyBiosource |
1Sample |
EUR 315 |
Plasma - Pediatric Samples - 5. Ages 15-17 Years Old |
|
MBS170633-5x1Sample |
MyBiosource |
5x1Sample |
EUR 4310 |
 Free Metanephrine - Normetanephrine ELISA kit - Plasma samples - Research |
|
BA-E-8300R |
ImmuSmol SAS |
1 kit |
EUR 951.48 |
|
Description: App. 1 year |
 3 Catecholamines ELISA kit Plasma & Urine samples - Research |
|
BA-E-6600R |
ImmuSmol SAS |
1 kit |
EUR 1364.04 |
|
Description: App. 1 year |
 Recombinant Biomphalaria obstructa Actin, cytoplasmic |
|
MBS1341829-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1160 |
Recombinant Biomphalaria obstructa Actin, cytoplasmic |
|
MBS1341829-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 915 |
Recombinant Biomphalaria obstructa Actin, cytoplasmic |
|
MBS1341829-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 1040 |
Recombinant Biomphalaria obstructa Actin, cytoplasmic |
|
MBS1341829-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 1185 |
Recombinant Biomphalaria obstructa Actin, cytoplasmic |
|
MBS1341829-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1305 |
 Active Human PAI-1 Functional Assay ELISA Kit for Non Plasma Samples |
|
MBS136003-1Kit |
MyBiosource |
1Kit |
EUR 595 |
Active Human PAI-1 Functional Assay ELISA Kit for Non Plasma Samples |
|
MBS136003-5Kits |
MyBiosource |
5Kits |
EUR 2150 |
Active Human PAI-1 Functional Assay ELISA Kit for Non Plasma Samples |
|
MBS136003-5x5Kits |
MyBiosource |
5x5Kits |
EUR 9935 |
) p47 phox, aa1-390, Recombinant, Human (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1) |
|
MBS635740-005mg |
MyBiosource |
0.05mg |
EUR 610 |
p47 phox, aa1-390, Recombinant, Human (NCF1, NOXO2, p47phox, neutrophil cytosolic factor 1, 47kD, chronic granulomatous disease, autosomal 1, Neutrophil cytosolic factor-1) |
|
MBS635740-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2600 |
 Rat Pulmonary Fibroblasts |
|
ABC-TC4204 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: The most abundant cell type in lung interstitium is fibroblasts. They resemble ordinary fibroblasts but have some distinguishing features, for example, they have long branching processes and gap junctions. |
 Human Pulmonary Fibroblasts |
|
ABC-TC3776 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: The most abundant cell type in lung interstitium is fibroblasts. They resemble ordinary fibroblasts but have some distinguishing features, for example, they have long branching processes and gap junctions. Their principle function is production of type III collagen, elastin, and proteoglycans of the extracellular matrix of the alveolar septa. Pulmonary fibroblasts (PF) play an important role in the repair and remodeling processes following injury. The controlled accumulation of fibroblasts to sites of inflammation is crucial to effective tissue repair after injury. Either inadequate or excessive accumulation of fibroblasts could result in abnormal tissue function. For example, the excess proliferation of fibroblasts contributes to the adventitial thickening observed during the development of hypoxia-induced pulmonary hypertension. HPF from Gentaur Research Laboratories are isolated from human lung tissue. HPF are cryopreserved at primary culture and delivered frozen. Each vial contains 5×10^5 cells in 1 ml volume. HPF are characterized by immunofluorescent method with antibody to fibronectin. HPF are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HPF are guaranteed to further expand for 15 population doublings at the condition provided by Gentaur Research Laboratories. |
 2019-nCoV IgG/IgM RapiCard InstaTest for Whole Blood/Serum/Plasma samples |
|
GEN-176552-50tests |
Cortez Diagnostic |
50 tests |
EUR 566.4 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
)) SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6007970-01mg |
MyBiosource |
0.1(mg |
EUR 665 |
SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6007970-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2850 |
SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6004601-01mL |
MyBiosource |
0.1(mL |
EUR 675 |
SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6004601-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2880 |
SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6008047-005mg |
MyBiosource |
0.05(mg |
EUR 630 |
SFTPB (SFTP3, Pulmonary Surfactant-associated Protein B, 18kD Pulmonary-surfactant Protein, 6kD Protein, Pulmonary Surfactant-associated Proteolipid SPL(Phe)) |
|
MBS6008047-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2680 |
 cDNA - Pulmonary Embolism: Lung |
|
C1236152Ld-5 |
Biochain |
40 reactions |
EUR 726.6 |
 Mini Samples ELISA Kit) Human Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087711-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5485 |
Human Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087711-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 370 |
Human Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087711-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 575 |
Human Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087711-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3030 |
Human Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087711-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
 Mini Samples ELISA Kit) Mouse Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087712-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5080 |
Mouse Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087712-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 355 |
Mouse Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087712-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 540 |
Mouse Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087712-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2835 |
Mouse Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087712-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 710 |
 Mini Samples ELISA Kit) Bovine Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087710-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 7980 |
Bovine Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087710-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 510 |
Bovine Retinol Binding Protein 4, Plasma (RBP4) Mini Samples ELISA Kit |
|
MBS2087710-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 810 |
Polycystic ovary syndrome (PCOS) is likely one of the commonest ovarian illnesses amongst ladies of reproductive age. The reproductive and metabolic traits of PCOS are underpinned by adipocyte dysfunction, particularly diminished adiponectin secretion. Based mostly on proof that niacin stimulates adiponectin secretion, this examine evaluated the results of niacin on adiponectin concentrations and reproductive traits in a rat mannequin of PCOS. PCOS was induced by single injection of 4mg kg-1 oestradiol valerate (i.m.), and PCOS teams have been administered orally with saline or niacin (10 or 25mg kg-1) every day for 30 days after PCOS induction.
